• MAPK10–KRT16 Signaling in NSCLC Metastasis

  2026-09-16

  The reference study defines a phosphorylation-dependent MAPK10/KRT16/RNF213 pathway that suppresses non-small cell lung cancer metastasis by promoting KRT16 ubiquitination and proteasomal degradation. Its combined cellular, animal, and clinical evidence positions MAPK10 as a metastasis-associated regulator and prognostic biomarker, while also clarifying which experimental conclusions remain specific to this pathway.

• EZ Cap™ EGFP mRNA: Practical Assay Guide

  2026-09-16

  EZ Cap™ EGFP mRNA (SKU R1002) provides a Cap 1 EGFP reporter mRNA input for testing delivery and reporter expression in research systems. It is appropriate for controlled assay development, but the supplied dossier does not define a universal dose, cell type, delivery method, readout window, or expected performance outcome.

• p-Tau Ser356, NUAK Inhibition, and Alzheimer’s Disease

  2026-09-15

  Taylor et al. link tau phosphorylation at Ser356 to Braak stage, neurofibrillary tangles, and synaptic localization in Alzheimer’s disease tissue. Their ex vivo experiments further show that NUAK inhibition lowers p-tau Ser356 in live human brain slices, while producing broader and potentially confounding protein losses in postnatal mouse cultures.

• Reproducible iPSC-to-RGC Differentiation

  2026-09-15

  Chavali et al. developed a chemically defined, non-genetic differentiation strategy that combines dual SMAD inhibition with canonical Wnt inhibition to generate retinal ganglion cells from induced pluripotent stem cells. The approach improved yield and reproducibility across experiments and enabled further Thy-1-positive enrichment, providing a practical platform for glaucoma modeling and RGC-focused drug discovery.

• Cefodizime: Applied Microbiology Workflows

  2026-09-14

  Cefodizime offers a practical way to model β-lactam activity across respiratory, urinary, and selected Gram-negative infection systems. This guide translates its PBP-directed mechanism, exposure profile, and immunomodulatory potential into reproducible assay workflows with built-in troubleshooting.

• Heparin Sodium as a Mechanistic Probe

  2026-09-14

  Heparin sodium is more than a standard anticoagulant reagent. Its defined action through antithrombin III, combined with the emerging role of heparan sulfate proteoglycans in plant-derived nanovesicle uptake, creates a compelling framework for translational researchers studying coagulation, cell-surface biology, and delivery mechanisms.

• 0.4% Trypan Blue Solution: Practical Guide

  2026-09-13

  0.4% Trypan Blue Solution supports rapid cell viability measurement and live/dead cell discrimination by staining cells with compromised membrane integrity. It is intended for research cell-counting and cytotoxicity workflows, not for diagnostic, clinical, or medical use.

• How Mixing Controls mRNA LNP Performance

  2026-09-12

  The Nature Communications study isolates primary mixing as a major determinant of mRNA lipid nanoparticle physicochemical properties and biological performance by comparing ten mixers under otherwise controlled formulation conditions. Its results show why manually prepared or laminar-flow LNPs may not predict the behavior of particles produced with turbulent-flow equipment at manufacturing scale.

• CNQX Workflows for AMPA/Kainate Research

  2026-09-11

  CNQX enables controlled separation of AMPA/kainate-driven excitation from NMDA-receptor signaling in electrophysiology, circuit studies, and cardiovascular neuroscience. This workflow-focused guide covers preparation, assay design, interpretation, and troubleshooting for reproducible non-NMDA receptor blockade.

• Açaí Extracts: Hepatocyte Toxicity and Drug Interactions

  2026-09-11

  This study integrates cytotoxicity testing, gene-expression analysis, and functional transporter assays to examine how consumer-relevant açaí extracts may affect human hepatic drug-disposition pathways. Its main finding is selective, preparation-dependent hepatocyte toxicity without significant induction of the tested CYP enzymes or transporters, offering a practical framework for botanical-drug interaction assessment.

• NFIA in Bone Homeostasis: Study Insights

  2026-09-10

  A 2026 Genes & Diseases study identifies nuclear factor I/A (NFIA) as a mesenchymal stem/progenitor-cell regulator that coordinates osteoclast and osteoblast differentiation. Its loss increases RANKL-dependent resorption and alters osteogenic and adipogenic programs, with excessive resorption predominating and reducing bone mass accrual.

• Sodium salicylate for NF-κB stromal assays

  2026-09-10

  Sodium salicylate offers a soluble, tunable NF-κB inhibitor workflow for separating inflammatory signaling from the sequential stromal remodeling reported in pancreatic cancer nanomedicine. This guide covers assay setup, concentration and storage decisions, 2D-to-3D validation, and troubleshooting for inflammation, oxidative stress, and immunology studies.

• DiI (DiIC18(3)) Plasma Membrane Probe Guide

  2026-09-09

  DiI (DiIC18(3)) is a lipophilic orange fluorescent membrane dye for visualizing plasma membrane distribution, membrane movement, and labeled cell populations in live or fixed samples. It is suitable for neuronal tracing, migration, adhesion, fusion, and lipoprotein workflows, but not for water-based staining or applications requiring stable intracellular organelle labeling after harsh permeabilization.

• Anti-ROR1 Antibody: Assay Workflows & Use Cases

  2026-09-09

  Anti-ROR1 Antibody (Zilovertamab) supports a practical path from receptor-binding assays to flow cytometry and functional signaling studies. This guide also shows how to use the product responsibly in exploratory liver-injury models without confusing a mechanistic hypothesis with established evidence.

• CNQX Workflow for AMPA/Kainate Circuit Mapping

  2026-09-08

  CNQX provides a practical way to separate AMPA/kainate-driven excitation from NMDA-dependent signaling in cellular, slice, and neurocardiovascular assays. This guide converts its receptor pharmacology into executable workflows, controls, and troubleshooting decisions for synaptic physiology and excitotoxicity research.

8152 records 1/544 page Next 12345 下5页 Last page